Highlights Biotest AG Xetra

Equities

BIO

DE0005227201

Real-time Estimate Tradegate Other stock markets 08:30:17 02/07/2024 BST			5-day change	1st Jan Change
42.2 ^EUR	-0.94%		+3.90%	0.00%

07-01	Kedrion Biopharma Inc. Selects by Biotest to Distribute Its Immunoglobulin Yimmugo in the U.S. Following Recent FDA Approval	CI
06-17	Biotest Receives FDA Approval for Innovative Yimmugo Immunoglobulin to Treat Primary Immunodeficiencies	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kedrion Biopharma Inc. Selects by Biotest to Distribute Its Immunoglobulin Yimmugo in the U.S. Following Recent FDA Approval	07-01	CI
Biotest Receives FDA Approval for Innovative Yimmugo Immunoglobulin to Treat Primary Immunodeficiencies	06-17	CI
Ex-dividend day for final dividend	05-07	FA
Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Biotest Launches New Plasma Collection Center in Germany	04-19	MT
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
Biotest Aktiengesellschaft Raises Earnings Guidance for the Year 2023	05/10/23	CI
Biotest Treats First Patient with Severe Community- Acquired Pneumonia in Phase III Trial with Trimodulin	12/09/23	CI
Biotest AG Announces US Food and Drug Administration Accepts Marketing Authorization Application for Immunoglobulin Yimmugo	07/09/23	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23	CI
Biotest's Hyperimmunoglobulin Cytotect® CP Receives Five Additional Marketing Authorisations in Europe	04/05/23	CI
Biotest AG Opens 12Th Plasma Collection Centre in Hungary	25/04/23	CI
Blood plasma specialist Biotest again expects operating loss	23/03/23	DP
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
Biotest Aktiengesellschaft Treats First Covid-19 Patients with Trimodulin in TRICOVID Phase III Trial	09/01/23	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Biotest Aktiengesellschaft Opens 12th Plasma Collection Centre in the Czech Republic	06/09/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biotest AG Xetra

Equities

BIO

DE0005227201

Highlights

Filters